Form 8-K - Current report:
SEC Accession No. 0001193125-18-047232
Filing Date
2018-02-15
Accepted
2018-02-15 16:06:11
Documents
8
Period of Report
2018-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d531554d8k.htm 8-K 21934
2 EX-1.1 d531554dex11.htm EX-1.1 174548
3 EX-5.1 d531554dex51.htm EX-5.1 9204
4 EX-99.1 d531554dex991.htm EX-99.1 9814
5 EX-99.2 d531554dex992.htm EX-99.2 9601
6 GRAPHIC g531554g0214123507067.jpg GRAPHIC 1595
7 GRAPHIC g531554g0214123702694.jpg GRAPHIC 1595
8 GRAPHIC g531554g66h99.jpg GRAPHIC 2725
  Complete submission text file 0001193125-18-047232.txt   235091
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 18617721
SIC: 2834 Pharmaceutical Preparations